19 Recruiting Myeloma Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceTop Recruiting Myeloma Studies
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Study of Belantamab Mafodotin as Pre- and Post-autologous Stem Cell Transplant and Maintenance for Multiple Myeloma
📍 University of Pennsylvania — Philadelphia, Pennsylvania
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
Ixazomib with Pomalidomide, Clarithromycin and Dexamethasone in Treating Patients with Multiple Myeloma
📍 University of California San Diego — La Jolla, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy
📍 University of Arkansas for Medical Sciences — Little Rock, Arkansas
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Daratumumab, Carfilzomib, Lenalidomide and Low Dose Dexamethasone (DKRd) in Newly Diagnosed, Multiple Myeloma
📍 The University of Chicago — Chicago, Illinois
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Elranatamab Post Cilta-cel in Patients With Clinical High Risk Relapsed Myeloma
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
A Multicentre, Non-Blinded Study Exploring Self-Administration of Chemotherapy in the Home Environment
📍 Arthur J.E. Child Comprehensive Cancer Centre — Calgary, Alberta
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
A Phase 1 With Extension Cohort, Single Arm, Single Center, Open Label Trial of Belantamab Mafodotin for the Treatment of High-Risk Smoldering Multiple Myeloma
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM
📍 Brigham and Women's Hospital — Boston, Massachusetts
View Study & Checklist ➔